BRPI0909770A2 - Vacina, e, kit - Google Patents

Vacina, e, kit

Info

Publication number: BRPI0909770A2
Authority: BR; Brazil
Prior art keywords: vaccine; kit
Prior art date: 2008-04-18

Application number

BRPI0909770-8A

Other languages

English (en)

Inventor

Antonius Arnoldus Christian Jacobs

Paul Vermeij

Ruud Philip Antoon Maria Segers

Carla Christina Schrier

Original Assignee

Intervet Int Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-04-18

Filing date

2009-04-16

Publication date

2015-08-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39496087&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0909770(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-04-16 Application filed by Intervet Int Bv filed Critical Intervet Int Bv

2015-08-11 Publication of BRPI0909770A2 publication Critical patent/BRPI0909770A2/pt

2021-09-28 Publication of BRPI0909770B1 publication Critical patent/BRPI0909770B1/pt

Links

229960005486 vaccine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Tropical Medicine & Parasitology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

BRPI0909770-8A 2008-04-18 2009-04-16 Vacina de antígenos não-vivos de lawsonia intracellularis, de mycoplasma hyopneumoniae e circovírus porcino BRPI0909770B1 (pt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US4618808P	2008-04-18	2008-04-18
EP08154765		2008-04-18
US61/046,188		2008-04-18
EP08154765.5		2008-04-18
PCT/EP2009/054517 WO2009127684A1 (en)	2008-04-18	2009-04-16	Vaccine for protection against lawsonia intracellularis, mycoplasma hyopneumoniae and porcine circo virus

Publications (2)

Publication Number	Publication Date
BRPI0909770A2 true BRPI0909770A2 (pt)	2015-08-11
BRPI0909770B1 BRPI0909770B1 (pt)	2021-09-28

Family

ID=39496087

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0909770-8A BRPI0909770B1 (pt)	2008-04-18	2009-04-16	Vacina de antígenos não-vivos de lawsonia intracellularis, de mycoplasma hyopneumoniae e circovírus porcino

Country Status (13)

Country	Link
US (2)	US20110033497A1 (pt)
EP (2)	EP2291195B2 (pt)
JP (2)	JP6026107B2 (pt)
CN (2)	CN106729695A (pt)
BR (1)	BRPI0909770B1 (pt)
CA (1)	CA2718787C (pt)
DK (2)	DK2291195T4 (pt)
ES (2)	ES2534502T5 (pt)
HU (1)	HUE038425T2 (pt)
PL (2)	PL2291195T5 (pt)
RU (1)	RU2496520C2 (pt)
TW (1)	TWI449533B (pt)
WO (1)	WO2009127684A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8834891B2 (en)	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
TWI551295B (zh)	2008-04-18	2016-10-01	英特威特國際股份有限公司	防備胞內勞森菌（Ｌａｗｓｏｎｉａｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
ES2534556T3 (es) *	2008-07-22	2015-04-24	Intervet International Bv	Bacteria Lawsonia intracellularis de un nuevo serotipo, vacuna basada en esa bacteria, anticuerpos adecuados para diagnosticar el nuevo serotipo de Lawsonia intracellularis e hibridomas para producir dichos anticuerpos
TWI627281B (zh)	2009-09-02	2018-06-21	百靈佳殷格翰家畜藥品公司	降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
WO2011141443A1 (en)	2010-05-11	2011-11-17	Intervet International B.V.	Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies
WO2013000876A1 (en)	2011-06-27	2013-01-03	Intervet International B.V.	An aqueous composition comprising a biological antigen and an acrylic acid polymer
SG11201403957WA (en) *	2012-01-13	2014-09-26	Boehringer Ingelheim Vetmed	Kit for producing a vaccine
US9474692B2 (en) *	2012-01-13	2016-10-25	Boehringer Ingelheim Vetmedica Gmbh	Kit for the preparation of a vaccinating agent
UA114504C2 (uk) *	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en)	2012-04-04	2015-09-01	Zoetis Services Llc	Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv та mycoplasma hyopneumoniae
CN103031258B (zh) *	2012-06-29	2014-12-17	普莱柯生物工程股份有限公司	新的猪肺炎支原体菌株及其疫苗组合物
CN104450559B (zh) *	2012-06-29	2017-09-22	普莱柯生物工程股份有限公司	新的猪肺炎支原体菌株及其疫苗组合物
EP2684959A1 (en) *	2012-07-10	2014-01-15	Laboratorios Hipra, S.A.	Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof
JP6488304B2 (ja) *	2013-12-03	2019-03-20	インターベットインターナショナルベー．フェー．	ローソニア・イントラセルラリス（ｌａｗｓｏｎｉａｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）及びブタサーコウイルス（ｐｏｒｃｉｎｅｃｉｒｃｏｖｉｒｕｓ）２に対するワクチン
CN105873604B (zh) *	2013-12-03	2020-01-14	英特维特国际股份有限公司	针对prrs和胞内劳森氏菌的猪疫苗
JP6605469B2 (ja) *	2013-12-03	2019-11-13	インターベットインターナショナルベー．フェー．	ブタサーコウイルス２型に対するワクチン
WO2016124620A1 (en) *	2015-02-04	2016-08-11	Intervet International B.V.	A vaccine for use against subclinical lawsonia infection in a pig
JP2018504423A (ja) *	2015-02-04	2018-02-15	インターベットインターナショナルベー．フェー．	豚における無症候性ローソニア感染症に対する使用のためのワクチン
EP3432920A1 (en) *	2016-03-23	2019-01-30	Intervet International B.V.	A vaccine for intradermal application against pcv2 and prrs virus infection
RU2018137034A (ru) *	2016-03-23	2020-04-23	Интервет Интернэшнл Б.В.	Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae
CN110087678B (zh) *	2016-12-23	2023-09-26	英特维特国际股份有限公司	用于猪的组合疫苗
EP3609533A1 (en) *	2017-04-13	2020-02-19	Intervet International B.V.	Vaccines containing swine pathogens for associated non-mixed use
CL2017002196A1 (es) *	2017-08-30	2017-11-17	Univ De Concepción	Vacuna recombinante contra enteropatía proliferativa en animales.
EP3720488A1 (en) *	2017-12-04	2020-10-14	Intervet International B.V.	Vaccination with replicon particles and oil adjuvant
JP7346417B2 (ja)	2017-12-18	2023-09-19	インターベットインターナショナルベー．フェー．	ブタインフルエンザａウイルスワクチン
BR112022024932A2 (pt)	2020-06-19	2022-12-27	Intervet Int Bv	Vacina contra vírus da influenza a suína compreendendo um constructo de ácido nucleico que possui uma ordem específica de genes
JP2023530135A (ja)	2020-06-19	2023-07-13	インターベットインターナショナルベー．フェー．	特定のウイルス系統の抗原をエンコードする核酸構築物を含むブタインフルエンザａウイルスワクチン
WO2021255225A1 (en)	2020-06-19	2021-12-23	Intervet International B.V.	Swine influenza a virus vaccine comprising a nucleic acid construct comprising first, second and third nucleic acid sequences encoding distinct neuraminidase antigens of the virus
US20230277649A1 (en)	2020-06-19	2023-09-07	Intervet Inc.	Swine influenza a virus vaccine comprising two distinct rna replicon particles

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0382271B1 (en) *	1989-02-04	1994-12-21	Akzo Nobel N.V.	Tocols as adjuvant in vaccine
US5714375A (en)	1995-06-05	1998-02-03	Nobl Laboratories, Inc.	Ileal symbiont intracellularis propagation in suspended host cells
US5885823A (en)	1995-06-05	1999-03-23	Nobl Laboratories, Inc.	Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
US7022328B1 (en) *	1995-11-30	2006-04-04	Australian Pork Limited	Therapeutic and diagnostic compositions
JP2004529854A (ja) *	2000-09-29	2004-09-30	アリゾナ・ボード・オブ・リージエンツ・オン・ビハーフ・オブ・ザ・ユニバーシテイー・オブ・アリゾナ	増殖性回腸炎のための改善されたワクチン及びその作製と使用の方法
ES2360225T3 (es)	2000-12-20	2011-06-02	Intervet International Bv	Vacuna contra lawsonia intracellularis.
US7321065B2 (en) *	2003-04-18	2008-01-22	The Regents Of The University Of California	Thyronamine derivatives and analogs and methods of use thereof
UA87665C2 (ru)	2003-07-25	2009-08-10	Берингер Ингельхайм Ветмедика, Инк.	Авирулентный изолят lawsonia intracellularis европейского происхождения, вакцина для иммунизации животных, применение заявленного авирулентного изолята как вакцины, способ получения вакцины, способ культивирования lawsonia intracellularis, способ диагностики пролиферативной энтеропатии свиней и способ получения антисыворотки к lawsonia intracellularis
TW200510524A (en) *	2003-07-25	2005-03-16	Boehringer Ingelheim Vetmed	Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof
KR20060134054A (ko)	2004-01-22	2006-12-27	인터벳 인터내셔널 비.브이.	로소니아 인트라셀룰라리스 서브유닛 백신
US20070212373A1 (en) *	2004-12-08	2007-09-13	Akzo Nobel N.V.	Lawsonia Intracellularis 26 Kd Subunit Vaccine
US8834891B2 (en) *	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
AU2006289102C1 (en) *	2005-09-09	2017-11-30	Intervet International B.V.	PCV-2 vaccine
US20080226669A1 (en)	2005-12-29	2008-09-18	Boehringer Ingelheim Vetmedica, Inc.	Multivalent pcv2 immunogenic compositions and methods of producing such compositions
PL2371383T3 (pl)	2005-12-29	2016-01-29	Boehringer Ingelheim Vetmedica Inc	Zastosowanie kompozycji immunogennej do zmniejszania objawów klinicznych u świń
CA2644195A1 (en)	2006-03-03	2007-09-13	Merial Limited	Mycoplasma hyopneumoniae vaccine
MX2008012972A (es)	2006-04-10	2009-01-16	Intervet Int Bv	Vacuna contra sindrome respiratorio reproductivo porcino atenuado vivo de micoplasma.
MX2008015164A (es)	2006-05-30	2008-12-12	Intervet Int Bv	Vacuna contra organismos de tipo rickettsia.
EP2242511A4 (en)	2008-01-23	2012-10-24	Boehringer Ingelheim Vetmed	IMMUNOGENIC COMPOSITIONS OF MYCOPLASMA HYOPNEUMONIAE PCV2, AND METHODS FOR PRODUCING SUCH COMPOSITIONS

2009
- 2009-03-30 TW TW098110513A patent/TWI449533B/zh active
- 2009-04-16 WO PCT/EP2009/054517 patent/WO2009127684A1/en not_active Ceased
- 2009-04-16 ES ES09732113T patent/ES2534502T5/es active Active
- 2009-04-16 CA CA2718787A patent/CA2718787C/en active Active
- 2009-04-16 EP EP09732113.7A patent/EP2291195B2/en active Active
- 2009-04-16 CN CN201611239977.4A patent/CN106729695A/zh active Pending
- 2009-04-16 PL PL09732113T patent/PL2291195T5/pl unknown
- 2009-04-16 BR BRPI0909770-8A patent/BRPI0909770B1/pt active IP Right Grant
- 2009-04-16 HU HUE13169835A patent/HUE038425T2/hu unknown
- 2009-04-16 PL PL13169835T patent/PL2633867T3/pl unknown
- 2009-04-16 ES ES13169835.9T patent/ES2666844T3/es active Active
- 2009-04-16 DK DK09732113.7T patent/DK2291195T4/da active
- 2009-04-16 JP JP2011504463A patent/JP6026107B2/ja active Active
- 2009-04-16 DK DK13169835.9T patent/DK2633867T3/en active
- 2009-04-16 EP EP13169835.9A patent/EP2633867B1/en not_active Revoked
- 2009-04-16 US US12/988,088 patent/US20110033497A1/en not_active Abandoned
- 2009-04-16 CN CN200980112991XA patent/CN102006884A/zh active Pending
- 2009-04-16 RU RU2010146950/15A patent/RU2496520C2/ru active
2013
- 2013-02-05 US US13/759,421 patent/US9084768B2/en active Active
2014
- 2014-09-05 JP JP2014180911A patent/JP6078504B2/ja active Active

Also Published As

Publication number	Publication date
RU2496520C2 (ru)	2013-10-27
EP2633867B1 (en)	2018-03-21
JP6078504B2 (ja)	2017-02-08
JP2015028038A (ja)	2015-02-12
DK2291195T4 (da)	2020-02-10
BRPI0909770B1 (pt)	2021-09-28
CA2718787A1 (en)	2009-10-22
ES2534502T5 (es)	2020-06-26
EP2291195A1 (en)	2011-03-09
WO2009127684A1 (en)	2009-10-22
TW201000123A (en)	2010-01-01
DK2633867T3 (en)	2018-05-28
CN102006884A (zh)	2011-04-06
CN106729695A (zh)	2017-05-31
CA2718787C (en)	2018-04-10
DK2291195T3 (en)	2015-05-11
US20110033497A1 (en)	2011-02-10
EP2291195B2 (en)	2019-11-13
JP6026107B2 (ja)	2016-11-16
RU2010146950A (ru)	2012-05-27
TWI449533B (zh)	2014-08-21
HUE038425T2 (hu)	2018-10-29
EP2291195B1 (en)	2015-02-25
JP2011516601A (ja)	2011-05-26
PL2291195T3 (pl)	2015-07-31
ES2666844T3 (es)	2018-05-08
US9084768B2 (en)	2015-07-21
EP2633867A1 (en)	2013-09-04
PL2633867T3 (pl)	2018-07-31
US20130183338A1 (en)	2013-07-18
PL2291195T5 (pl)	2020-06-29
ES2534502T3 (es)	2015-04-23

Legal Events

Date	Code	Title	Description
2017-09-05	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2018-10-09	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2020-11-10	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2021-08-10	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-09-28	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/04/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

Publication	Publication Date	Title
BRPI0909770A2 (pt)	2015-08-11	Vacina, e, kit
BRPI0907231A2 (pt)	2019-09-24	pirrolpirimidinas e pirrolpiridinas
ATE450271T1 (de)	2009-12-15	Impfstoff
DK2114993T3 (da)	2012-10-22	Vaccine
BR112012002349A2 (pt)	2015-10-13	composto,e, uso do mesmo
DK2349430T3 (da)	2019-11-11	KATETERISERINGANORDNING og -kit
DE602009000234D1 (de)	2010-11-11	msignals
BRPI0907376A2 (pt)	2015-07-14	Fotobiorretador
BRPI0917205A2 (pt)	2015-11-10	vacina polivalente
BRPI0914649A2 (pt)	2015-07-07	Piprazolo-quinazolinas
CR10571A (es)	2009-05-14	Vacuna virica recombinante
DE602008003972D1 (de)	2011-01-27	Sitzrücklehnungsmechanismus
DE602008003521D1 (de)	2010-12-30	Sitzrücklehnungsmechanismus
DK2300238T3 (da)	2013-12-16	Skyggebillede-sikkerhedstræk
DE602008003970D1 (de)	2011-01-27	Strahlstromkalibriersystem
BRPI0911625A2 (pt)	2015-08-04	Métodos
BRPI0907522A2 (pt)	2019-09-24	biarlamidas
DE112009000183A5 (de)	2011-02-03	Sicherheitsvorreiber
BRPI0809678A2 (pt)	2014-10-07	Métodos
BRPI0909634A2 (pt)	2015-09-22	2-aminoquinolinas
DE602009000862D1 (de)	2011-04-28	Gehwagenbremse
DE112009001946A5 (de)	2011-07-14	Mobelauszugsführung
DE602009000488D1 (de)	2011-02-10	Obstvereinzelvorrichtung
BRPI0907863A2 (pt)	2019-09-24	pirrolopirimidinacarboxamidas
BRPI0909637A2 (pt)	2015-09-22	2-aminoquinolinas